Skip to content
Bethanidine
Tenathan (bethanidine) is a small molecule pharmaceutical. Bethanidine was first approved as Tenathan on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Bethanidine sulfate
Tradename
Company
Number
Date
Products
TENATHANA.H. Robins CompanyN-017675 DISCN1982-01-01
2 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
C02: Antihypertensives
C02C: Antiadrenergic agents, peripherally acting
C02CC: Guanine derivatives, peripherally acting antiadrenergic agents
C02CC01: Betanidine
HCPCS
No data
Clinical
Clinical Trials
7 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic neoplasmsD010190EFO_0003860C25112
Eosinophilic esophagitisD057765EFO_0004232K20.011
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Type 2 diabetes mellitusD003924EFO_0001360E1111
Esophageal motility disordersD015154K22.411
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
TracheobronchomalaciaD05508911
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameBETHANIDINE
INNbetanidine
Description
Bethanidine is a member of guanidines. It has a role as an adrenergic antagonist and an antihypertensive agent.
Classification
Small molecule
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C/N=C(\NC)NCc1ccccc1
Identifiers
PDB
CAS-ID55-73-2
RxCUI1523
ChEMBL IDCHEMBL1201260
ChEBI ID37937
PubChem CID2368
DrugBankDB00217
UNII IDW8S3YM7AUU (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 422 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
187 adverse events reported
View more details